Boyds, MD, United States of America

Ling-Ling An

USPTO Granted Patents = 9 

 

 

Average Co-Inventor Count = 6.6

ph-index = 6

Forward Citations = 86(Granted Patents)


Company Filing History:


Years Active: 2009-2014

Loading Chart...
Loading Chart...
Loading Chart...
9 patents (USPTO):Explore Patents

Title: The Innovations of Ling-Ling An

Introduction

Ling-Ling An is a prominent inventor based in Boyds, MD (US). She has made significant contributions to the field of biotechnology, particularly in the development of monoclonal antibodies. With a total of 9 patents to her name, her work has had a profound impact on medical diagnostics and treatment.

Latest Patents

Among her latest patents are innovative methods for detecting factor D using anti-factor D antibodies. These inventions relate to humanized anti-human Factor D monoclonal antibodies, including their nucleic acid and amino acid sequences. The patents also cover the cells and vectors that harbor these antibodies, which are crucial for preparing compositions and medicaments aimed at treating diseases associated with excessive or uncontrolled complement activation. These antibodies are valuable for diagnostics, prophylaxis, and treatment of various diseases.

Career Highlights

Ling-Ling An has worked with notable companies in the biotechnology sector, including Genentech, Inc. and MedImmune Limited. Her experience in these organizations has allowed her to refine her skills and contribute to groundbreaking research and development in her field.

Collaborations

Some of her notable coworkers include Herren Wu and Sek Chung Fung, who have collaborated with her on various projects throughout her career.

Conclusion

Ling-Ling An's contributions to the field of biotechnology through her patents and collaborations highlight her role as an influential inventor. Her work continues to pave the way for advancements in medical treatments and diagnostics.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…